Alexandria, VA – According to filings with the U.S. Securities and Exchange Commission, Avicena North America is raising $44,416,500.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Tony Fitzgerald played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Avicena North America
Avicena is a private company backed by the Australian government. Our mission is to develop low-cost ultra-high-throughput molecular diagnostic and screening instruments to detect SARS-CoV-2 and other pathogens. Learning from the experience of the global pandemic our platform is designed for pandemic-scale throughput, being able to screen up to 92,160 individuals eith saliva samles every 24 hours. Major near-term applications include large-scale sentinel testing of entire suburbs, regions, and cities; high-density environments such as airports and cruise ships; and crowded places such as factories complexes, major public events, and religious festivals.

To learn more about Avicena North America, visit http://avicenasystems.com/

Contact:
Tony Fitzgerald, Chief Executive Officer
706-372-2124
tony@avicenasystems.com
https://www.linkedin.com/in/tony-fitzgerald-90a25541/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved